Nicollet Mall

Latest stories

10d
Finance and Commerce
Data centers built to withstand bad storms, bad actorsFrom left: Jim Wolford, CEO and owner of Atomic Data, and Blake Talley, directo
Data centers built to withstand bad storms, bad actors
Finance and Commerce / Posted 10 days ago
From left: Jim Wolford, CEO and owner of Atomic Data, and Blake Talley, director of the company’s Network Operations Center, leased 15,000 square feet in the former Federal Reserve Bank of Minneapolis building. (Staff photo: Bill Klotz) Data centers... Read more
11d
Business Wire
Inotek Pharmaceuticals Corporation Announces Closing of $79.2 Million Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional SharesLEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ:
Inotek Pharmaceuticals Corporation Announces Closing of $79.2 Million Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Business Wire / Posted 11 days ago
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) (the “Company” or “Inotek”), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases,... Read more
17d
Business Wire
Inotek Pharmaceuticals Corporation Announces Pricing of $68.9 Million Public OfferingLEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ:
Inotek Pharmaceuticals Corporation Announces Pricing of $68.9 Million Public Offering
Business Wire / Posted 17 days ago
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) (the “Company” or “Inotek”), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases,... Read more
18d
Business Wire
Aimmune Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesBRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc., today announced
Aimmune Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Business Wire / Posted 18 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc., today announced the closing of its initial public offering of 11,499,999 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and... Read more
23d
Finance and Commerce
Finessing downtown Minneapolis park’s design delays public inputCurrent design plans for the Downtown East Commons prioritize green space and r
Finessing downtown Minneapolis park’s design delays public input
Finance and Commerce / Posted 23 days ago
Current design plans for the Downtown East Commons prioritize green space and room for events. (Submitted image) Construction started this week on the 4.2-acre park at the center of an effort to revitalize Minneapolis’ Downtown East section, but... Read more
24d
Business Wire
Imprivata Announces Pricing of Offering of Common Stock by Selling StockholdersLEXINGTON, Mass.--(BUSINESS WIRE)--Imprivata®, (NYSE: IMPR), the healthcare IT
Imprivata Announces Pricing of Offering of Common Stock by Selling Stockholders
Business Wire / Posted 24 days ago
LEXINGTON, Mass.--(BUSINESS WIRE)--Imprivata®, (NYSE: IMPR), the healthcare IT security company, today announced the pricing of the previously announced underwritten public offering of 4,566,666 shares of its common stock by existing stockholders as... Read more
24d
Business Wire
Aimmune Therapeutics Announces Pricing of Initial Public OfferingBRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. today announced t
Aimmune Therapeutics Announces Pricing of Initial Public Offering
Business Wire / Posted 24 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. today announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and... Read more
28d
Crain's Detroit Business
Goal for Greektown: No cars, more trafficPhoto by LARRY PEPLIN Greektown by day — but on weekends, a pedestrian plaza.
Goal for Greektown: No cars, more traffic
Crain's Detroit Business / Posted 28 days ago
Photo by LARRY PEPLIN Greektown by day — but on weekends, a pedestrian plaza. Pay no mind to that man swallowing fire on Monroe Street. He, outdoor dining and other live entertainment options might become a regular fixture on the main city blocks... Read more
1m
Business Wire
Genocea Biosciences, Inc. Announces Pricing of $50 Million Public OfferingCAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a b
Genocea Biosciences, Inc. Announces Pricing of $50 Million Public Offering
Business Wire / Posted a month ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced the pricing of its public offering of 3,850,000 shares of its common... Read more

People in this news